Matches in SemOpenAlex for { <https://semopenalex.org/work/W1563140897> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W1563140897 endingPage "8" @default.
- W1563140897 startingPage "652" @default.
- W1563140897 abstract "Scintigraphy with 123I-Tyr-3-octreotide has several major drawbacks as regards its metabolic behavior, its cumbersome preparation and the short physical half-life of the radionuclide. The use of another radiolabeled analog of somatostatin, 111In-DTPA-D-Phe-1-octreotide, has consequently been proposed. DTPA-D-Phe-1-octreotide can be radiolabeled with 111In in an easy single-step procedure. DTPA-D-Phe-1-octreotide is cleared predominantly via the kidneys. Fecal excretion of radioactivity amounts to only a few percent of the administered radioactivity. For the radiation dose to normal tissues, the most important organs are the kidneys, the spleen, the urinary bladder, the liver and the remainder of the body. The calculated effective dose equivalent is 0.08 mSv/MBq. Optimal 111In-DTPA-D-Phe-1-octreotide scintigraphic imaging of various somatostatin receptor-positive tumors was obtained 24 hr after injection. In the six patients studied, tumor localization with 123I-Tyr-3-octreotide and with 111In-DTPA-D-Phe-1-octreotide were found to be similar. However, the normal pituitary is more frequently visualized with the latter radiopharmaceutical. In conclusion, 111In-DTPA-D-Phe-1-octreotide appears to be a sensitive somatostatin receptor-positive tissue-seeking radiopharmaceutical with some remarkable advantages: easy preparation, general availability, appropriate half-life and absence of major interference in the upper abdominal region, because of its renal clearance. Therefore, 111In-DTPA-D-Phe-1-octreotide may be suitable for use in SPECT of the abdomen, which is important in the localization of small endocrine gastroenteropancreatic tumors." @default.
- W1563140897 created "2016-06-24" @default.
- W1563140897 creator A5001350334 @default.
- W1563140897 creator A5009298643 @default.
- W1563140897 creator A5015610675 @default.
- W1563140897 creator A5024667317 @default.
- W1563140897 creator A5047989262 @default.
- W1563140897 creator A5060570558 @default.
- W1563140897 creator A5086485579 @default.
- W1563140897 creator A5088889332 @default.
- W1563140897 creator A5090367243 @default.
- W1563140897 creator A5090550889 @default.
- W1563140897 date "1992-05-01" @default.
- W1563140897 modified "2023-09-23" @default.
- W1563140897 title "Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide." @default.
- W1563140897 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1349039" @default.
- W1563140897 hasPublicationYear "1992" @default.
- W1563140897 type Work @default.
- W1563140897 sameAs 1563140897 @default.
- W1563140897 citedByCount "146" @default.
- W1563140897 countsByYear W15631408972012 @default.
- W1563140897 countsByYear W15631408972013 @default.
- W1563140897 countsByYear W15631408972014 @default.
- W1563140897 countsByYear W15631408972015 @default.
- W1563140897 countsByYear W15631408972017 @default.
- W1563140897 countsByYear W15631408972018 @default.
- W1563140897 countsByYear W15631408972019 @default.
- W1563140897 countsByYear W15631408972022 @default.
- W1563140897 countsByYear W15631408972023 @default.
- W1563140897 crossrefType "journal-article" @default.
- W1563140897 hasAuthorship W1563140897A5001350334 @default.
- W1563140897 hasAuthorship W1563140897A5009298643 @default.
- W1563140897 hasAuthorship W1563140897A5015610675 @default.
- W1563140897 hasAuthorship W1563140897A5024667317 @default.
- W1563140897 hasAuthorship W1563140897A5047989262 @default.
- W1563140897 hasAuthorship W1563140897A5060570558 @default.
- W1563140897 hasAuthorship W1563140897A5086485579 @default.
- W1563140897 hasAuthorship W1563140897A5088889332 @default.
- W1563140897 hasAuthorship W1563140897A5090367243 @default.
- W1563140897 hasAuthorship W1563140897A5090550889 @default.
- W1563140897 hasConcept C126322002 @default.
- W1563140897 hasConcept C134018914 @default.
- W1563140897 hasConcept C185592680 @default.
- W1563140897 hasConcept C2776297358 @default.
- W1563140897 hasConcept C2779902710 @default.
- W1563140897 hasConcept C2781025020 @default.
- W1563140897 hasConcept C2989005 @default.
- W1563140897 hasConcept C2993559085 @default.
- W1563140897 hasConcept C71924100 @default.
- W1563140897 hasConcept C80115893 @default.
- W1563140897 hasConceptScore W1563140897C126322002 @default.
- W1563140897 hasConceptScore W1563140897C134018914 @default.
- W1563140897 hasConceptScore W1563140897C185592680 @default.
- W1563140897 hasConceptScore W1563140897C2776297358 @default.
- W1563140897 hasConceptScore W1563140897C2779902710 @default.
- W1563140897 hasConceptScore W1563140897C2781025020 @default.
- W1563140897 hasConceptScore W1563140897C2989005 @default.
- W1563140897 hasConceptScore W1563140897C2993559085 @default.
- W1563140897 hasConceptScore W1563140897C71924100 @default.
- W1563140897 hasConceptScore W1563140897C80115893 @default.
- W1563140897 hasIssue "5" @default.
- W1563140897 hasLocation W15631408971 @default.
- W1563140897 hasOpenAccess W1563140897 @default.
- W1563140897 hasPrimaryLocation W15631408971 @default.
- W1563140897 hasRelatedWork W1542976343 @default.
- W1563140897 hasRelatedWork W1778714316 @default.
- W1563140897 hasRelatedWork W2028767994 @default.
- W1563140897 hasRelatedWork W2092253945 @default.
- W1563140897 hasRelatedWork W2148426378 @default.
- W1563140897 hasRelatedWork W2396455948 @default.
- W1563140897 hasRelatedWork W2583211791 @default.
- W1563140897 hasRelatedWork W2744424417 @default.
- W1563140897 hasRelatedWork W4235008636 @default.
- W1563140897 hasRelatedWork W2157138278 @default.
- W1563140897 hasVolume "33" @default.
- W1563140897 isParatext "false" @default.
- W1563140897 isRetracted "false" @default.
- W1563140897 magId "1563140897" @default.
- W1563140897 workType "article" @default.